During the past decade, St Vincents Birmingham conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "St Vincents Birmingham" are "Blood Loss, Surgical" (1 trials), "Lower Respiratory Tract Illness" (1 trials), "Lumbar Spinal Stenosis" (1 trials) and "Respiratory Tract Infection" (1 trials). Many other conditions were trialed in "St Vincents Birmingham" in a lesser frequency.

Most popular intervention types in "St Vincents Birmingham" are "Biological" (2 trials), "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "RSVpreF" (2 trials), "Ecallantide" (1 trials) and "MILD" (1 trials). Other intervention names were less common.

The vast majority of trials in "St Vincents Birmingham" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "St Vincents Birmingham". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in St Vincents Birmingham, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in St Vincents Birmingham, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".